Key facts
- Notable investors include Tech Incubator Program for Startup, Kiwoom Investment, Series Ventures, Busan United Holdings (Busan), Comes Investment — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Tecure
- ·The full record, as it builds
Funding rounds
No funding rounds for Tecure are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Tecure
Developer of laser treatment technology designed for reflux esophagitis. The company's technology provides convenient treatment to medical professionals through research and product development for endoscopic treatment based on precision laser technology, enabling the healthcare industry to offer safe treatments for intractable diseases of various organs.
- Sector
- Healthcare
- HQ
- Busan, South Korea
- Founded
- 2020
- Employees
- 4
- Website
- tecure.com/
- Ownership
- Privately Held (backing)
Tecure doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Tecure shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Tecure in its N-PORT filings yet. We sweep new filings monthly.